DENTSPLY SIRONA (XRAY) is back in focus after recent coverage highlighted soft constant currency revenue growth and diminishing returns on capital, putting management’s past and current decisions under a brighter spotlight for investors.

The recent concerns around soft constant currency revenue growth and weaker returns on capital sit against a share price of US$11.47 and a 1 month share price return of a 22% decline, with a 1 year total shareholder return of a 20.3% decline and a 5 year total shareholder return of an 80.14% decline, indicating that longer term momentum has been fading.

If this has you rethinking where growth might come from in healthcare, it could be worth broadening your watchlist with a curated set of 33 healthcare AI stocks

With the share price under pressure, a reported loss of US$598 million and an intrinsic value estimate that sits above where the stock trades today, you have to ask: is there a mispriced recovery story here, or is the market already discounting future growth?

Most Popular Narrative: 74.8% Undervalued

According to the most followed narrative, DENTSPLY SIRONA's fair value of $45.50 sits well above the last close at $11.47, which puts a spotlight on what might be driving such a wide gap.

Dentsply Sirona operates in a corner of healthcare that rarely attracts hype but consistently demands precision. As one of the world's largest dental equipment and consumables providers, the company sits upstream from patient demand, selling to dental practices rather than consumers. That position shapes everything about its business, from revenue stability to growth expectations.

The narrative, according to yiannisz, leans heavily on durable dental demand, recurring consumables revenue, and a business model built around long product cycles and practice level economics, all feeding into optimistic assumptions on future profitability and margins without spelling out the exact path in the headline numbers.

Result: Fair Value of $45.50 (UNDERVALUED)

However, you also need to weigh risks such as the recent US$598 million loss and soft constant currency revenue growth, which could challenge the durability story that investors focus on.

Next Steps

With sentiment clearly mixed, it helps to look past the headlines and test the data yourself. Pay attention to both the potential upside and the warning signs highlighted in the 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If DENTSPLY SIRONA is on your radar, do not stop there. Broaden your opportunity set with focused stock ideas that match the kind of portfolio you want to build.

• Target potential mispricings by scanning companies that combine quality traits with attractive valuations using the 62 high quality undervalued stocks.
• Strengthen your income stream by reviewing companies offering robust yields through the 12 dividend fortresses.
• Prioritise resilience by checking out companies with sturdy finances via the solid balance sheet and fundamentals stocks screener (39 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.